References
- Brandt S. J., Peters W. P., Atwater S. K., Kurtzberg J., Borowitz M. J., Jones R. B., Shall E. J., Bast R. C., Gilbert C. J., Oette D. H. The effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconsti-tution after high dose chemotherapy and autologous bone marrow transplantation. N Engl J Med 1988; 318: 869
- Nemunaitis J., Buckner C. D., Appelbaum F. R., Higano C. S., Mori M., Bianco J., Epstein C., Lipani J., Hansen J., Storb R., Thomas D. E., Singer J. W. Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation. Blood 1991; 77: 2065
- Nemunaitis J., Singer W., Buckner C. D., Hill R., Storb R., Thomas E. D., Appelbaum F. R. Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood 1988; 72: 834
- Taylor K. M. D., Jagannath S., Spitzer G., Spinolo J. A., Tucker S. L., Fogel B., Cabanilla F. F., Hagemeister F. B., Souza L. M. Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease. J Clin One 1989; 7: 1791